摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Trifluoro-methanesulfonic acid (3aR,5aS,8aS,8bS)-7,7-dimethyl-2,2-dioxo-tetrahydro-2λ6-[1,3,2]dioxathiolo[4,5-d][1,3]dioxalo[4,5-b]pyran-5a-ylmethyl ester | 835894-57-0

中文名称
——
中文别名
——
英文名称
Trifluoro-methanesulfonic acid (3aR,5aS,8aS,8bS)-7,7-dimethyl-2,2-dioxo-tetrahydro-2λ6-[1,3,2]dioxathiolo[4,5-d][1,3]dioxalo[4,5-b]pyran-5a-ylmethyl ester
英文别名
[(1S,2S,6R,9S)-11,11-dimethyl-4,4-dioxo-3,5,8,10,12-pentaoxa-4lambda6-thiatricyclo[7.3.0.02,6]dodecan-9-yl]methyl trifluoromethanesulfonate;[(1S,2S,6R,9S)-11,11-dimethyl-4,4-dioxo-3,5,8,10,12-pentaoxa-4λ6-thiatricyclo[7.3.0.02,6]dodecan-9-yl]methyl trifluoromethanesulfonate
Trifluoro-methanesulfonic acid (3aR,5aS,8aS,8bS)-7,7-dimethyl-2,2-dioxo-tetrahydro-2λ<sup>6</sup>-[1,3,2]dioxathiolo[4,5-d][1,3]dioxalo[4,5-b]pyran-5a-ylmethyl ester化学式
CAS
835894-57-0
化学式
C10H13F3O10S2
mdl
——
分子量
414.334
InChiKey
ZSSZUVLJWOGCJQ-JAKMQLQISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    25
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    140
  • 氢给体数:
    0
  • 氢受体数:
    13

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Trifluoro-methanesulfonic acid (3aR,5aS,8aS,8bS)-7,7-dimethyl-2,2-dioxo-tetrahydro-2λ6-[1,3,2]dioxathiolo[4,5-d][1,3]dioxalo[4,5-b]pyran-5a-ylmethyl ester 在 palladium on activated charcoal sodium azide 、 氢气磺酰胺 作用下, 以 1,4-二氧六环乙醇N,N-二甲基甲酰胺 为溶剂, 23.0 ℃ 、289.58 kPa 条件下, 反应 48.5h, 生成 (1S,2S,6R,9S)-11,11-dimethyl-4,4-dioxo-9-[(sulfamoylamino)methyl]-3,5,8,10,12-pentaoxa-4lambda6-thiatricyclo[7.3.0.02,6]dodecane
    参考文献:
    名称:
    Comparison of Sulfamate and Sulfamide Groups for the Inhibition of Carbonic Anhydrase-II by Using Topiramate as a Structural Platform
    摘要:
    This paper examines the relative effectiveness of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II (CA-H). Topiramate (1) and its sulfamide analogue 4, and 4,5-cyclic sulfate 6 and its sulfamide analogue 5, were compared for inhibition of human CA-II. A colorimetric assay, based on the pH shift that accompanies hydration of carbon dioxide, and an esterase assay were used. For these bioisosteric pairs, 1/4 and 6/5, the sulfamate compound was markedly more potent than its sulfamide counterpart. A similar, large difference in potency was also observed for the sulfamate/sulfamide pairs 14/15 and 16/17. These results indicate that the sulfamide moiety is not particularly suitable for obtaining potent carbonic anhydrase inhibition. A discussion of this structure-activity relationship with respect to the interactions of 1 and 6 with CA-H from published X-ray data is presented. A metabolic acidosis study was performed in rats with 1, 4, 6, and 2, and the results are discussed with respect to the degree of inhibition of CA-II in vivo.
    DOI:
    10.1021/jm040124c
  • 作为产物:
    描述:
    三氟甲磺酸酐2,3-O-(isopropylidene)-4,5-O-sulfonyl-β-D-fructopyranose吡啶 作用下, 以 二氯甲烷 为溶剂, 反应 2.0h, 以83%的产率得到Trifluoro-methanesulfonic acid (3aR,5aS,8aS,8bS)-7,7-dimethyl-2,2-dioxo-tetrahydro-2λ6-[1,3,2]dioxathiolo[4,5-d][1,3]dioxalo[4,5-b]pyran-5a-ylmethyl ester
    参考文献:
    名称:
    Comparison of Sulfamate and Sulfamide Groups for the Inhibition of Carbonic Anhydrase-II by Using Topiramate as a Structural Platform
    摘要:
    This paper examines the relative effectiveness of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II (CA-H). Topiramate (1) and its sulfamide analogue 4, and 4,5-cyclic sulfate 6 and its sulfamide analogue 5, were compared for inhibition of human CA-II. A colorimetric assay, based on the pH shift that accompanies hydration of carbon dioxide, and an esterase assay were used. For these bioisosteric pairs, 1/4 and 6/5, the sulfamate compound was markedly more potent than its sulfamide counterpart. A similar, large difference in potency was also observed for the sulfamate/sulfamide pairs 14/15 and 16/17. These results indicate that the sulfamide moiety is not particularly suitable for obtaining potent carbonic anhydrase inhibition. A discussion of this structure-activity relationship with respect to the interactions of 1 and 6 with CA-H from published X-ray data is presented. A metabolic acidosis study was performed in rats with 1, 4, 6, and 2, and the results are discussed with respect to the degree of inhibition of CA-II in vivo.
    DOI:
    10.1021/jm040124c
点击查看最新优质反应信息

文献信息

  • Comparison of Sulfamate and Sulfamide Groups for the Inhibition of Carbonic Anhydrase-II by Using Topiramate as a Structural Platform
    作者:Bruce E. Maryanoff、David F. McComsey、Michael J. Costanzo、Coralie Hochman、Virginia Smith-Swintosky、Richard P. Shank
    DOI:10.1021/jm040124c
    日期:2005.3.1
    This paper examines the relative effectiveness of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II (CA-H). Topiramate (1) and its sulfamide analogue 4, and 4,5-cyclic sulfate 6 and its sulfamide analogue 5, were compared for inhibition of human CA-II. A colorimetric assay, based on the pH shift that accompanies hydration of carbon dioxide, and an esterase assay were used. For these bioisosteric pairs, 1/4 and 6/5, the sulfamate compound was markedly more potent than its sulfamide counterpart. A similar, large difference in potency was also observed for the sulfamate/sulfamide pairs 14/15 and 16/17. These results indicate that the sulfamide moiety is not particularly suitable for obtaining potent carbonic anhydrase inhibition. A discussion of this structure-activity relationship with respect to the interactions of 1 and 6 with CA-H from published X-ray data is presented. A metabolic acidosis study was performed in rats with 1, 4, 6, and 2, and the results are discussed with respect to the degree of inhibition of CA-II in vivo.
查看更多

同类化合物

苄基二亚苄基-α-D-甘露吡喃糖苷 苄基2-C-甲基-3,4-O-(1-甲基亚乙基)-BETA-D-吡喃核糖苷 艾日布林中间体,艾瑞布林中间体 艾日布林中间体 脱氧青蒿素 甲基6-脱氧-3,4-O-异亚丙基-beta-L-甘油-吡喃己糖苷 甲基3,4-异亚丙基-beta-L-阿拉伯糖吡喃糖苷 甲基3,4-O-异亚丙基-beta-L-赤式-吡喃戊-2-酮糖 甲基3,4-O-(氧代亚甲基)-beta-D-吡喃半乳糖苷 甲基 3,4-O-异亚丙基吡喃戊糖苷 甲基 2,3-O-羰基-4,6-O-异亚丙基-alpha-D-吡喃甘露糖苷 果糖二丙酮氯磺酸酯 果糖二丙酮 托吡酯杂质7 托吡酯N-甲基杂质 托吡酯-13C6 托吡酯 史氏环氧化恶唑烷酮甲基催化剂 双丙酮半乳糖 双丙酮-L-阿拉伯糖 六氢二螺[环己烷-1,2'-[1,3]二氧杂环戊并[4,5]吡喃并[3,2-d][1,3]二恶英-8',1''-环己烷]-4'-醇 [(3aS,5aR,7R,8aR,8bS)-7-(羟基甲基)-2,2,7-三甲基四氢-3aH-二[1,3]二氧杂环戊并[4,5-b:4',5'-d]吡喃-3a-基]甲基氨基磺酸 D-半乳醛环3,4-碳酸 6-脱氧-6-碘-1,2:3,4-二-o-异亚丙基-α-d-半乳糖吡喃糖苷 6-叠氮基-6-脱氧-1,2:3,4-二-o-异亚丙基-d-半乳糖吡喃糖苷 6-O-乙酰基-1,2:3,4-二-O-异亚丙基-alpha-D-吡喃半乳糖 4,5-O-(1-甲基乙亚基)-beta-D-吡喃果糖 3alpha-羟基去氧基蒿甲醚 3-羟基去oxydihydroartemisinin 3,5,11-三氧杂-10-氮杂三环[6.2.1.02,6]十一碳-2(6),7,9-三烯 3,4-O-异亚丙基-L-阿拉伯糖 3,4-O-(苯基亚甲基)-D-核糖酸 D-内酯 3,4,6-三-O-苄基-beta-D-吡喃甘露糖-1,2-(甲基原乙酸酯) 2,6-脱水-5-脱氧-3,4-O-(氧代亚甲基)-1-O-(三异丙基硅烷基)-D-阿拉伯糖-己-5-烯糖 2,3:4,6-二-o-异亚丙基-d-甘露糖苷甲酯 2,3:4,5-二-O-(1-甲基亚乙基)-beta-D-吡喃果糖甲基((((1-(甲硫基)亚乙基)氨基)氧基)羰基)酰胺基亚硫酸酯 2,3:4,5-二-O-(1-甲基亚乙基)-beta-D-吡喃果糖 1-叠氮基硫酸酯 2,3-脱异亚丙基托吡酯 2,3-O-羰基-alpha-d-吡喃甘露糖 2,3-O-(1-甲基亚乙基)-beta-D-吡喃果糖1-氨基磺酸酯 2,3-4,5-二-O-异亚丙基-1-O-甲基-beta-吡喃果糖 2,3,5-三邻苄基-1-o-(4-硝基苯甲酰基)-d-阿拉伯呋喃糖 2,2,2',2'-四甲基四氢螺[1,3-二氧戊环-4,6'-[1,3]二氧杂环戊并[4,5-c]吡喃]-7'-醇 10-乙氧基-1,5,9-三甲基-11,14,15-三氧杂四环[10.2.1.04,13.08,13]十五烷 1-{[(1R,2S,6R)-4,4-二甲基-3,5,10,11-四氧杂三环[6.2.1.02,6]十一烷-7-基]氧基}-3-{[(1S,2R,6S)-4,4-二甲基-3,5,10,11-四氧杂三环[6.2.1.02,6]十一烷-7-基]氧基}-2-丙胺 1-[(3aS,5aR,8aR,8bS)-2,2,7,7-四甲基四氢-3aH-二[1,3]二氧杂环戊并[4,5-b:4',5'-d]吡喃-3a-基]甲胺 1-O-ACETYL-2,3,4,6-DI-O-ISOPROPYLIDENE-Α-D-MANNOPYRANOSE1-O-乙酰基-2,3,4,6-二-O-异亚丙基-Α-D-吡喃甘露糖 1-O-ACETYL-2,3,4,6-DI-O-ISOPROPYLIDENE-Α-D-MANNOPYRANOSE1-O-乙酰基-2,3,4,6-二-O-异亚丙基-Α-D-吡喃甘露糖 1,6-脱水-2,3-O-异亚丙基-β-D-甘露吡喃糖 1,6-去氢-2,3-O-亚苄基-beta-D-吡喃甘露糖